Nymox

Reports from Nymox describe recent developments

Published in Medical Patent Law Weekly, March 14th, 2007

Reports from Nymox describe recent developments.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nymox.

Report 1: Nymox Pharmaceutical Corporation's (NYMX) AlzheimAlert test is years ahead of the competition, according to Brian Doyle, Nymox's senior manager for Worldwide Sales and Marketing.

The urine-based test, which measures levels of a protein-based biomarker for Alzheimer disease, is available to physicians in major markets, including Europe and the United States. A recent article in The Wall Street Journal described competing tests in this area that employ measuring...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2007-03-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry